22nd International Leprosy Congress

Main Congress

Home
Main Congress

Schedule ILC Update - Google Drive

Schedule ILC Update : Sheet1


1	DAY 1, July 7 2025 - Monday
2	Room	Ballroom
3	Time	Ballroom
4	7:30 – 7:33 AM	Safety Briefing
5	7:33 – 7:37 AM	National Anthem
6	7:37 – 7:40 AM	Welcome Dance
7	7:40 – 8:45 AM	Inauguration session (@ 5min) 1. 7:40–7:45 AM Ketut Kwartantaya Winaya – ILC 2025 Bali Region Chairman 2. 7.45 – 7.50 AM M. Yulianto Listiawan - ILC 2025 Chairman 3. 7.50 – 7.55 AM Hendra Gunawan, KSMHI Chairman 4. 7.55 – 8.00 AM Prasetyadi Mawardi – Kolegium Chairman 5. 8.00 – 08.05 AM Hanny Nilasari – Perdoski Chairman 6. 8.05 – 8.10 AM Permata Al - Kadri – People affected invited speaker 7. 8.10 – 8.15 AM P. Narasimha Rao – President, ILA 8. 8.15 – 8.20 AM Kazim Hizbullah Sanikullah – Representative of Regional Director WPRO 9. 8.20 – 8.25 AM Saima Wazed – WHO Regional Director SEARO & Head of WHO Global Leprosy Programme 10. 8.25 – 8.30 AM Yohei Sasakawa – Chairman of the Nippon Foundation 11. 8.30 – 8.35 AM I Wayan Koster – Bali Governor 12. 8.35 – 8.45 AM H.E. Budi Gunadi Sadikin – Minister of Health of the Republic of Indonesia
8
9
10
11
12
13
14
15
16
17	8:45 – 8:55	Opening Remark - Ceremonial
18	8:55 – 9:00	Photo Session & Closing Session
19	09:00 – 10:00 AM	Break					HIgh Level Meeting
20	10:00 AM – 12:30 PM	Plenary 1: MC Opening 10.00–10.05 Chairperson: Medhi Denisa Alinda 1. 10.05-10.25 Use of High-Resolution Ultrasound in the diagnosis of Pure Neuritic Leprosy – Sujai Suneetha 2. 10.25-10.45 Marco Andrew C Frade 3. 10.45–11.05 Accelerating Zero Leprosy Through Multi-layered Advocacy – Takahiro Nanri (Sasakawa) QnA (5 min) 11.10-11.15 Chairperson: Flora Ramona Sigit Prakoeswa 4. 11.15–11.35 Gaps Between Patient’s Charter Principles and Reality by Providing a Patient-Centric Perspective on Existing Challenges – Amar Bahadur Timalsina, GPZL, Nepal 11.35–11.55 Beyond Good Intentions: Navigating the Government’s Commitments and Concrete Actions in Ending Leprosy – Agus Wijayanto, CEO of NLR Indonesia Foundation 6. 11.55 – 12.15 Finding the needle in haystack：Best Practices for Skin NTDs control in Low Epidemic Areas from Shandong Province, China – Zhang Furen 7. 12.15 – 12.35 Face of Leprosy – Diana Lockwood QnA (5min)					10:00 – 10:30 Press Conference
21	12.30 AM – 1:30 PM	Lunch Break
22	PARALLEL SESSIONS
23	Rooms	Room 1: Mengwi 1	Room 2: Mengwi 2	Room 3: Mengwi 3	Room 4: Mengwi 5	Room 5: Mengwi 6	Room 6: Mengwi 7	Room 7: Mengwi 8	Room 8: Legian 1	Dry Workshop 1: Legian 2	Dry Workshop 2: Pecatu 1 & 2
24	1:30 – 3.00 PM MC in each room	Theme: Epidemiology and Leprosy Control Lead talk + Chairperson: How do we know we are making progress towards leprosy elimination? - Marco Andrey C Frade	Lead talk + Chairpersons: Epidemiology of Leprosy and Control Verification of interruption of transmission of leprosy and elimination of leprosy disease. Including indicators and cutoffs – Person affected - Bali	Lead talk + Chairperson: Role of vaccines in leprosy in stopping transmission - Veronica Schmitz	Lead talk + Chairperson: A Road Ahead- Outlining the GPZL Strategic Pathway (15 minutes) - Ritu Ghosh From GPZL	Theme: Lead talk + Chairperson: Leprosy Susceptibility: Genetic Variations Regulate Innate and Adaptive Immunity, and Disease Outcome – Yonghu sun	Theme: Management of complications Lead talk + Chairperson: Leprosy in children – a critical component of leprosy elimination – Sasakawa Health Foundation ●Ciro Martins Gomes, National Leprosy Program, Ministry of Health, Brazil ● Erei Remon, National Leprosy Program, Ministry of Health, Kiribati ● Lebora Jeevamalar Kunaradnam, Leprosy Peoples Association - Sri Lanka ● Saba Lambert, Chair, WHO Technical Expert Group on Childhood leprosy ● Vivek Lal, Team Leader, WHO Global Leprosy Programme	Maximizing the capacity and participation of organizations of people affected by leprosy in Africa – Sasakawa Health Foundation ● Chair/Facilitator: Tesfaye Tadesse Haile, Coordinator of Programs in Africa, SHF & Member, WHO Technical Advisory Group for Leprosy ● Co-Chair:Dr. Alice Cruz Program Advisor (Human Rights issues), SHF & former UN Special Rapporteur on the Elimination of Discrimination against Persons Affected by Leprosy (Hansen's disease) and their Family Members ● Representative, Organization of people affected by leprosy in Nigeria – Lilibeth Evarestus, National coordinator, Purple Hope Initiative, Nigeria ● Representative, Organization of people affected by leprosy in some country in Africa ● Papa Mamadou, President, Association Senegalaise de Lutte Contre la Lepre et les Maladies Tropicales Negligees (ASCL/MTN), Senegal ● Brima kpeh, Manager, National Association for Persons Affected by Leprosy (NAPAL), Sierra Leone	Chairperson: Yulia Siskawati Antara Oral free papers (6+1): Leprosy (Hansen’s Disease) Cases Among the Homeless Population Attended by the Street Clinic Program in Belém, Pará, Brazil 0 - Patrícia Fagundes da Costa Leprosy & Migration in India: outcome from a 3-yr pilot across 4 states in India - John Kurian George Migration and associated risk of severe disease among Newly diagnosed leprosy cases in a tertiary leprosy hospital in Chhattisgarh - RASHMI NAYAK Nerve function recovery after decompression of Median Nerve Decompression and recovery of nerve functions in leprosy: a retrospective study from tertiary care leprosy hospital - MATHANRAJ DAVID Leprosy awareness among people living in the tea gardens in Northeast Bangladesh - Meherul Rizwan Aumi The Role of Neutrophil-to-Lymphocyte Ratio in Predicting the Occurrence and Severity of Erythematous Nodosum Leprosum: A Systematic Review – Hapsari Kinanthi	Dry Workshop 1: GLMI Workshop Hope Rises International The Global Leprosy Mapping Initiative (Epco Hasker) - Using Geospatial Intelligence to Interrupt Leprosy Transmission: From Case Mapping to Targeted Interventions in Nepal (Nand Lal Banstola) - Results of mapping of leprosy cases in Senegal based on retrospective data for 2013-2023 (Louîs Hyacinthe Zoubi) - Geospatial Mapping of Leprosy and Other Socially Determined Infectious Diseases to Guide In-Service Training of Health Workers and Active Case-Finding (Josafa Barreto) - The WHO DHIS2 tool with a GIS module added on (Kate Shih) - Use of Kobotools to collect GIS data, a practical example (Rian Snijders)	Dry Workshop 2: Leprosy Friendly Village Approach: Driving Case-Finding and Stigma Reduction with Community Ownership and Evaluating Impact NLR Speakers: •⁠ ⁠Teky Budiawan •⁠ ⁠Sioly Soempiet Chairperson: Astri Ferdiana
25	1:30 – 3.00 PM MC in each room	Oral free papers (5): 1. Utility of Molecular Point-of-Care Testing (POCT) in the Early Diagnosis of Leprosy - Vinay Kumar Pathak 2. Effectiveness of 10-Year Retrospective Contact IT Tracing in Leprosy Case Detection Campaign (LCDC) 2024, West Bengal - ARUPKUMAR CHAKRABARTTY 3. Association of HLA class 1 alleles with leprosy: a case control study from an endemic area of India- Neel Prabha 4. Barriers To Seeking Healthcare Services And Contributing Factors To Grade 2 Disability Among Women Affected By Leprosy In Telangana, India â€“ A Qualitative Study-Charlotte Nehring 5. High-Resolution Ultrasound in Leprosy Neuropathy: What Lies Beyond the Cross-Sectional Area? - Marco Andrey Cipriani Frade	Oral free Paper (4): Whole genome based genotyping of Mycobacterium leprae from India for refining the molecular epidemiological investigations into the transmission of leprosy bacilli - Pushpendra Singh	Oral free papers (5): Advancing clinical development of LepVax, a Leprosy Vaccine with Therapeutic and Prophylactic Potential – Veronica Schmitz Pereira BCG Vaccination and Leprosy: Assessing Protective Efficacy and Treatment Response - APOORVA SHARMA Revolutionizing ENL Management: The Promising Role of the Mycobacterium indicus pranii (MIP) Vaccine in Recalcitrant Cases - SUNIL KUMAR GUPTA Molecular study on the transmission of drug-resistant strains of Mycobacterium leprae among household contacts of resistant cases of leprosy patients - RAHUL SHARMA Outcomes of Methotrexate and Prednisolone study in Erythema Nodosum Leprosum - MaPs in ENL - Barbara de Barros	Oral free papers (5): Global Partnership for Zero Leprosy (GPZL) Zero Transmission Symposium: ifu Operational approaches to interrupt transmission of Mycobacterium leprae - Willem van Brakel Challenges and Opportunities in the Development and Implementation of Zero Leprosy Roadmaps in Low-Endemic Settings: Experiences from Bolivia, Pakistan, and Togo -Anil Fastenau Roadmap towards Zero Leprosy in Pakistan: 2025–2030. - Anil Fastenau Scenario of childhood leprosy in the post elimination era: A retrospective study from a tertiary leprosy care hospital of north India - REETA DEVI High Mobility Box Group-1 (HMGB-1) as Potential Biomarker to Erythema Nodosum Leprosum (ENL) of Leprosy-Rizki Amelia Noviyanthi	Oral free papers (5): Qualitative exploration of potential links between spatially dispersed but phylogenetically connected leprosy patients: an interdisciplinary study in the Comoros - Maya Ronse Handgrip strength and functionality in individuals affected by leprosy, their household contacts and schoolchildren in endemic areas: Correlation with biomarkers of Mycobacterium leprae Infection - Renatto Castro Conde Addressing treatment dosing challenges using food vehicles in pediatric patients with leprosy - RAKESH CHUGH Burden and clinical spectrum of childhood leprosy: A retrospective analysis from North India - AANCHAL BANSAL Design, technical evaluation, and pilot study of a low-cost tool for assessment of autonomic nerve function impairment in leprosy (TAIL) - Arjan J. Knulst
26	3:00 – 3:30 PM	Break
27	Rooms	Room 1: Mengwi 1	Room 2: Mengwi 2	Room 3: Mengwi 3	Room 4: Mengwi 5	Room 5: Mengwi 6	Room 6: Mengwi 7	Room 7: Mengwi 8	Room 8: Legian 1	Room 9: Legian 2	Room 10: Pecatu 1 & 2
28	3:30 – 5:00 PM	Chairperson: Nanny Herwanto Oral free papers (7): Have technological advances improved our understanding of immune responses and are they contributing to the development of vaccines and the treatment of leprosy reactions? - Bernard Naafs Validation of the Leprosy Elimination Framebuwork and the Leprosy Elimination Monitoring Tool - Willem H van Brakel Transforming Leprosy Diagnostics: A Microchip-Based Point-of-Care Real-Time PCR in Indian Clinical Settings - Itu Singh Detection of Mycobacterium leprae in Airborne Samples from Hospital Environments Using the PCR Method - Dinar Adriaty An Alternative Strategy to Enhance Leprosy Surveillance: Leveraging Community Counsellors for Early Detection and Transmission Control - AMALADOSS ANTONY SAMY Endgame Strategy for Leprosy in the Maldives - David Blok Detection of an Abundance of Acid-Fast Bacilli from Leprosy's “Immune Zones.” – Pradantya Hanifa Yudiarini	Lead talk + Chairperson: Histoid leprosy: implications and management – Dhelya Widasmara	Lead talk + Chairperson Reaction in leprosy – Srilekha Penna	Theme: Diagnostic aspects Lead talk + Chairperson: The role of dermoscopy as leprosy diagnostic tool – Tarun Narang	Chairperson: Randy S. Nugraha	Lead talk + Chairperson: Role of methotrexate as corticosteroid-sparing agent in leprosy reactions – Steve Walker	Lead talk + Chairperson: Monitoring discrimination and taking evidence-based action against it: empowering persons affected by leprosy and their representative organizations through access to knowledge, knowledge production and evidence-informed advocacy – Sasakawa Health Foundation ● Chair/Facilitator: Alice Cruz, Program Advisor (Human Rights issues), SHF & former UN Special Rapporteur on the Elimination of Discrimination against Persons Affected by Leprosy (Hansen's disease) and their Family Members ● Representative, Saksham Kushthantey Swabhimani Sanstha (SKSS) in India Milind Sukdev Barsinge ● Representative, Movement for the Reintegration of People Affected by Hansen’s Disease (MORHAN) Piauí in Brazil – Francilene Mesquita	Chairperson: Medhi Denisa	Theme: Leprosy in special populations Lead talk + Chairperson: Leprosy in children – Hendra Gunawan	Lead talk: Treatment of reactions and prevention of disabilities – an important aspect of management of leprosy – Sasakawa Health Foundation ● Chair/Facilitator:V R Pemmaraju, Program Advisor for Medical issues, SHF ● Representative, National Leprosy Program, Ministry of Health in Nepal ● Representative, National Leprosy Program, Ministry of Health in Indonesia ● Representative, Netherlands Leprosy Relief, Indonesia – Teky Budiawan, Medical Director, Netherlands Leprosy Relief, Indonesia ● Representative, PerMaTa, Indonesia – Al Kadri, Representative, PerMaTa, Indonesia ● Representative, WHO Technical Advisory Group for leprosy – Indira Kahawita
29	3:30 – 5:00 PM		Oral free papers (4): A case series of Histoid leprosy from a tertiary care centre - VISHALAKSHI SURESH PANDIT Histoid Leprosy : Re-emerging in the 21st Century- A Case Series Highlighting the Gaps in Leprosy Control - PENALA HARSHINI The Role of Forming Field Hansenologists in Strengthening Leprosy Diagnosis in Mato Grosso, Central-West Brazil-Claudio Guedes Salgado Secondary drug resistance among Leprosy patients attending a tertiary care center in Bihar, Eastern India: a case series of 12 cases - Swetalina Pradhan	Oral free papers (4): ASSESSMENT OF THE EFFECT OF COVID-19 ON THE FREQUENCY AND WORSENING OF LEPROSY REACTIONS - Veronica Schmitz Misdiagnosis of Leprosy: A case series - Reejana Shrestha Beyond the Pilot: RIMOXCLAMIN's Therapeutic Impact in a Larger Brazilian Hansen’s Disease Population - a comparative study -Marco Andrey Cipriani Frade Viability Assessment of Mycobacterium leprae in MB-Relapse patients using Mouse Foot Pad Model: Insights into Drug Resistance and Molecular Diagnostics -Krishus Nepal	Oral free papers (4): Seeing vs. Feeling: The Correlation Between Tibial Nerve Ultrasound Findings and Plantar Sensory Loss in Leprosy - Marco Andrey Cipriani Frade Integrating Kobo Toolbox with HMIS/DHIS2 for Enhanced Leprosy Surveillance and Reporting in Nepal: A Scalable Model- PIN-WEI SHIH Development and Evaluation RLEP Droplet Digital PCR, RT-PCR, Anti Drug Loci RT-PCR to Diagnose Leprosy - LIU JIAN Government disability schemes for people affected by leprosy in India: a qualitative study of barriers to access and impact on beneficiaries’ economic situation, mental health and ability to lead a dignified life. - Bahadir Celiktemur	Oral free papers (7): MFGE8-dependent cell fusion facilitates the formation and function of Langhans giant cells in leprosy infection disease- Haiqin Jiang Study of quality of life using DLQI in Leprosy patients in tertiary care centre in Central India -Vivek Kumar Dey Evaluation of alternative Anti-Leprosy Regimens for Patients with Highly Bacillated Rifampicin-Resistant Cases - Vandana Elkana Survey on laboratory capacity of microbial diagnosis of leprosy and detection of antimicrobial resistance -Emmanuelle Cambau Towards Zero Leprosy and Discrimination: Climate-Adapted and Gender-Inclusive Advocacy for Bangladesh - MONIKA BISWAS Case Report of Unusual Presentation of Leprosy- Histoid Leprosy - NEETA VINCENT MAXIMUS Strengthening comprehensive mental health and psycho-social impact on people affected by leprosy - John Kurian George	Oral free papers (4): Clinical factors resulting in exclusion from Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum - MaPS in ENL -Barbara de Barros Early Detection and Source Tracing of Leprosy in Child: A Crucial Approach to Effective Management and Prevention - Novita Ifamela Analysis of newly diagnosed high BI leprosy patients during and after 1 year of MDT - Sujai Evidence-Driven Hotspot Identification to Accelerate Leprosy Transmission Interruption: First Experiences from MoLEP, Tanzania- Tanja Barth-Jaeggi		Oral free papers (7): What does a dignified life look like to people affected by leprosy? -Suresh Dhondge The importance of preserving the history of Hansen’s Disease (leprosy) -Norana Abdul Rahman The Social and Economic Independence Project for Individuals affected by Hansenâ€™s disease: Three Decades of Impact and Achievements- Sangkwon Jung Leprosy in Universal Health Coverage: Is it adequately covered in Nepal?- Rabindra Baskota Enhancing Leprosy Control in Nepal: The Impact of Single-Dose Rifampicin Prophylaxis - Nand Lal Banstola Skin and Disability Camps for promoting early case detection & prevention of disabilities - Ancily Francis Use of handheld ultrassingound (Philips Lumify) for the early detection of leprosy and evaluation of its value as compared to a conventional USG machine - Sundeep Chaitanya/Sujai Suneetha	Oral free papers (4): Clinical Profile of Leprosy in Children Under 10 Years in Nepal: A 29-Year Review - BISHWANATH ACHARYA Analysis of the efficacy of Langhans giant cells in controlling cutaneous mycobacterial infections - WANG,ZHENZHEN Effective healthcare and socioeconomic support can help prevent worsening of disability due to leprosy - Philemon Das Children Affected by Leprosy: An Overlooked Dimension of Leprosy-Related Stigma and Discrimination - Polu Waheduzzaman (representing Dr. Mowmita Basak)
30
31	DAY 2, July 8 2025 - Tuesday
32	Room	Ballroom
33	Time	Ballroom
34	09.00 – 10.30 AM	Plenary 2: MC Opening 09.00–09.05 Chairpersons: Bhushan Kumar 09.05–09.25 Practical Applications of SDR-PEP Implementation as a Cornerstone of a Transmission Interruption Project (15 min) Peter Steinmann, President, GPZL and Head of Unit, Swiss Tropical and Public Health Institute, Switzerland 09.25–09.45 Highlighting Innovative Research and Program Strategies for Zero Transmission- conclusions and recommendations from the Zero Transmission Symposium (15 min) Wim van Brakel, ILA Secretary and Medical Director, GPZL, NLR International, Amsterdam, Netherlands 09.45–10.05 Leprosy Control in Africa – Roch Christian Johnson, 10.05–10.25 Emerging Needs and Priorities in Leprosy: The Role of ILEP – Geoff Warne, ILEP QnA (5 min)linu
35	10:30 – 11:00 AM	Break
36	11.00 AM – 12.30 PM	Plenary 3: MC Opening 11.00–11.05 Chairpersons: Sujai Suneetha 11.05–11.25 Early Detection of Leprosy: Understanding the Role of Point-of-Care Diagnostic Methods (serology, basic haematological examination) – M. Yulianto Listiawan 11.25–11.45 Empowering Youth as Agents of Change in Eliminating NTDs: Drawing Attention to Leprosy Education through Miller’s Pyramid – Sri Linuwih Menaldi 11.45–12.05 MDT for Leprosy: Unmet Needs and Challenges in Current Practice – P. Narasimha Rao 12.05–12.25 – Beatriz Miranda Galarza QnA (15 min)
37	12:30 – 2:00 PM	Novartis Lunch Symposium Topic: Interruption of Transmission with Contact Screening along with Post-exposure Prophylaxis with single dose rifampicin (SDR) List of Speakers: 1. Dr Vivek Lal (WHO) 2. Dr Rabindra Baskota (MOHP, Nepal) 3. Mr Amar Bahadur Timalsina (IDEA Nepal) 4. Dr Wim van Brakel (NLR)
38	Rooms	Room 1: Mengwi 1	Room 2: Mengwi 2	Room 3: Mengwi 3	Room 4: Mengwi 5	Room 5: Mengwi 6	Room 6: Mengwi 7	Room 7: Mengwi 8	Room 8: Legian 1	Room 9: Legian 2	Dry Workshop 3: Pecatu 1 & 2
39	2:00 – 3:00 PM	Lead talk + Chairperson: Breaking the Chain: SDR-PEP, PEP++, and the End of Leprosy ● Liesbeth Mieras, Coordinator for Research and Advocacy, NLR International ● Teky Budiawan, Senior Technical Adviser, NLR Indonesia.	Theme: Clinical aspects Lead talk + Chairpersons: Leprosy relapse-sharing session: clinical aspects of leprosy relapse – Vivek V Pai	Theme: Diagnostic aspects Lead talk + Chairpersons: Hansenologist practice for early diagnosing leprosy – Claudio Salgado	Theme: Social Aspects Lead talk + Chairpersons: Quality of Life of People affected – Renni Yuniati	Theme: Therapeutic aspects Lead talk + Chairpersons: Establishment and evaluation of a simple detection method for rifampicin-resistant M. leprae using the LAMP method – Koichi Suzuki	Theme: Management of complications Lead talk + Chairpersons: The immunological aspects of ENL – Deana Alisa Hagge	Theme: Indian session Session Theme:Real-World Challenges in Management of Leprosy: Lessons from India; – Jointly organized by IADV; IAL Chairperson of Session: Sujai Suneetha, President IAL Session I. Chairpersons: Bhushan Kumar & Sendhil Kumaran Talk 1: Challenges Issues in Clinical Management of Leprosy cases in India – Santoshdev Rathod - 12 min Talk 2– Emerging Drug Resistance in Leprosy: Challenges, Surveillance, and Future Strategies – Tarun Narang - 12 min Session II. Chairpersons: Srilekha Penna, ILEP Co-Ordinator, India Panel Discussion: 30 min: Real World Challenges in Leprosy Control in India Chairperson: Sunil Dogra Panelists: 1. Vivek Pai 2. Joydeepa Darlong 3. Itu Singh 4. K Rajyalaxmi 5. Nirmala Devi P 6. Sunil K Gupta 7.Swetalina Pradhan	Chairpersons: Astri Ferdiana Oral Free Paper (4): Leprosy Friendly Village: Behaviour Change Initiative to Reduce Stigma in Communities and Healthcare Workers - Sioly Soempiet Exploratory Study on the Leprosy Post-Exposure Prophylaxis (LPEP) program in West Bengal – a Qualitative Perspective – Ashok Agarwal Assessing the Impact of Training on Healthcare Workers’ Capacity to Diagnose Leprosy and Skin Diseases: Preliminary Results from the PEP4LEP & PEP4LEP2.0 Projects – PEP4LEP & PEP4LEP 2.0 Consortium - Robin van Wijk, et al. Selfcare knowledge and skill transfer for leprosy patient for the first time for simple ulcer in in-patient department of LLHSC - Ankita Raskoti Magar	Theme: Disability and rehabilitation - Lead talk + Chairpersons: Skin care in leprosy – Flora Ramona Sigit Prakoeswa	Wound care in leprosy and Rehabilitation Complication – KALBE 1.⁠ ⁠ Sandy Qlintang 2.⁠ ⁠⁠ Eko Setiawan
40	2:00 – 3:00 PM	Oral free papers (2): 1. DEDIKASI-App Trial for Enhancing Awareness and Early Detection - Ulfah Abqari 2. Assessing the Activity and Participation Limitation of Hansen’s disease by SALSA and P - Scale - A Cross- Sectional Study from Hanzhong Leprosy Hospital, Shaanxi Province, China – Chenxiaohua	Oral free papers (2): Antimicrobial resistance testing for new and relapse cases of leprosy- Experiences of a Regional Apex Laboratory from India - APARNA SRIKANTAM The clinical spectrum of ocular complications among people affected by leprosy at a rural tertiary care centre in Melghat region of Maharashtra - Saurabh Sharad Deshmukh	Oral free papers (2): Differential cell-mediated immune responses in individuals seropositive for LID-1 and PGL-1 antigens-LUCIA A O FRAGA Efficiency of the Sensory Mapping Score for Hansen’s Disease Diagnosis and Follow-up: A Functional Cure Criterion? - Marco Andrey Cipriani Frade	Oral free papers (2): Health-related quality of life in Methotrexate and Prednisolone study in Erythema Nodosum Leprosum -MaPs in ENL participants at enrolment -cross-sectional study to assess the utility of the Dermatology Life Quality Index in ENL - Barbara de Barros Understanding the natural history of erythema nodosum leprosum to help define clinical classifications – an historically informed approach - Barbara de Barros	Oral free papers (2): Evaluation of the diagnostic efficacy of Loop mediated isothermal amplification (LAMP) assay from nasal swabs and slit skin smears in pediatric leprosy - Dr Raj Kamal Molecular detection of drug resistance in new, relapses and reaction cases of leprosy at the Referral Center in Mumbai, India. -Anju Vilas Wakade	Oral free papers (2): An update on the immunological aspects of Erythema Nodosum Leprosum (ENL) - Deanna A. Hagge Unveiling distinct immunological profiles in leprosy patients and household contacts using antibody-omics - Jessica K. Fairley			Oral free papers (2): Evaluation of a self-help intervention to promote the health and wellbeing of marginalised people including those living with leprosy in Nepal: a prospective, observational, cluster-based, cohort study with controls. -Dilip Shrestha Gastrocnemius Recession, an Alternative Method, for Lengthening Achilles Tendon in Posterior Tibial Tendon Transfer for Foot Drop Correction - PRADIP SAPKOTA
41	3.00 – 3.30 PM	Break
42	Rooms	Room 1: Mengwi 1	Room 2: Mengwi 2	Room 3: Mengwi 3	Room 4: Mengwi 5	Room 5: Mengwi 6	Room 6: Mengwi 7	Room 7: Mengwi 8	Room 8: Legian 1	Room 9: Legian 2	Room 10: Pecatu 1 & 2
43	3.30-5.00 PM	- Lead talk + Chairperson: New Case Detection – Francesca Cando Gajete	Lead talk + Chairperson: When to suspect leprosy relapse: a diagnostic dilemma - Sunil Dogra	Lead talk + Chairperson: Challenges in diagnosing leprosy based on pathological examination - Sujai Suneetha	Chairperson: Linda Astari	Lead talk + Chairperson: Comprehensive Management of Leprosy in China – Furen zhang	Lead talk + Chairperson: Update on treatment of Type 2 reaction; management of steroid dependent ENL – Diana Lockwood	Theme: all about leprosy Chairperson: Menul Umborowati Oral free papers (6+1): Impact of TLMTI’s Inclusive Empowerment Project: Advancing Community-Based Disability Management in Cuddalore District, Tamil Nadu, India – MANIVANNAN GOVINDARAJLU Tracking Leprosy Incidence among Family Contacts: Lessons from Palghar, an Endemic Tribal District in Maharashtra, India - PRAKASH RAMCHANDRA DEWARKAR Preliminary results of PEP4LEP (2.0), a chemoprophylaxis implementation trial in Mozambique, Ethiopia and Tanzania.– PEP4LEP & PEP4LEP 2.0 - Liesbeth Mieras, et al. Foot Amputation in Leprosy with Verrucous Carcinoma ; A Rare Case Report - Elza Amelia Firdaus TECHansen: Satisfaction of Professionals and Patients with the Donation of Assistive Technology Materials for Hansen’s Disease - SUSILENE MARIA TONELLI NARDI Thermography in leprosy for autonomic nerve impairment study ‘TAIL project’ - Suraj Maharjan PEP4LEP 2.0 & PEP4LEP IMPLEMENTATION TRIAL ON INTEGRATED SKIN SCREENING AND RIFAMPICIN AS POST-EXPOSURE PROPHYLAXIS FOR CONTACTS OF PEOPLE AFFECTED BY LEPROSY IN ETHIOPIA, MOZAMBIQUE AND TANZANIA - Anne Schoenmakers	Theme: Portuguese Session Chair: Patrícia D. Deps Co-chair: Marco Andrey Cipriani Frade Program: Impacts of South-South Cooperation in the Fight Against Hansen’s Disease: A Partnership Between Angola and Brazil. Speaker: Ciro M. Gomes – Coordinator of the National Hansen’s Disease Program, Brazil. Angola’s Fight Against Hansen’s Disease: Current Scenario and Future Perspectives. Speaker: Ernesto Afonso – Coordinator of the National Hansen’s Disease Program, Angola. Zoonotic Transmission of Mycobacterium leprae in the Americas and Its Impact on Hansen’s Disease Control. Speaker: Patrícia D. Deps – Vice President for the Americas, International Leprosy Association (ILA); Professor, Federal University of Espírito Santo, Brazil. Warnings About the Diagnosis of Hansen’s Disease in the Field: A Reality We Are Not Seeing or Do Not Want to Recognize? Speaker: Marco Andrey C. Frade – ILA Counsellor; President of the Brazilian Society of Hansenology; Full Professor of Dermatology, Ribeirão Preto Medical School, University of São Paulo, Brazil.	Chairperson Mufqi H. Priyanto Oral Free Paper (7) A randomised Trial of Autologous blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in leprosy neuropathic foot: The TABLE Trial result – Dr Indra Bahadur Napit The Diagnostic Edge: Nerve Biopsy in Pure Neuritic Hansen's Disease - Boina kinnera Effectiveness of Community Based Inclusive Development approach in Chikhaldara and Dharni blocks of Amravati district among Person affected by Leprosy and Challenges faced by them - Suresh Dhondge Impact of Community Engagement and Involvement in Leprosy Research - Anju Adhikari Implementation of combined community-based screening and treatment for active Leprosy, Tuberculosis and Latent Tuberculosis Infection with mass chemoprophylaxis with single dose rifampicin to reduce leprosy transmission. - Warwick John Britton Combination of Dual Antileprotic Drug with High Dose Systemic Corticosteroid and Antibiotics as Effective Treatment for Lucio Phenomenon: A Rare Case Series - Dila Muflikhy Putri Association between Neuropathic Pain and Somatosensory Impairment in Leprosy Patients – Dhan Maya Saru	Theme: Chinese Session Leprosy as a Model for Investigating Immune Evasion Mechanisms in Intracellular Bacteria – Hong Liu A Novel Model and Key Technologies for the Prevention and Control of Leprosy in China – Hongsheng Wang Internal Migration and Leprosy in Shanghai from 2000 to2023: an Epidemiological Study of New Cases – Jianyu Zhu Outcomes of alternative therapy in HLA-B*13:01 positive leprosy patients without dapsone versus conventional MDT in negative patients: A Comparative Effectiveness Study – Zhenzhen Wang
44	3.30-5.00 PM	Oral free papers (4): Profile, trends and reasons for delay in diagnosis of new leprosy patients in Madhesh Province, Nepal - Kiran Jha Nerve function impairment among new untreated leprosy patients at diagnosis and during Multidrug Therapy at Lalgadh Leprosy Hospital and Services Centre - Krishna Prasad Subedi Application of point-of-care quantitative immunodiagnostic test for detection of Mycobacterium leprae infection in a high endemic area in Brazil - Antoniella de Aguiar, Louise Pierneef, Hilma Solange Lopes Souza, Carla Pires, Marília Brasil Xavier, Marcelo Távora Mira and Annemieke Geluk.	Oral free papers (4): 1. Integrative immune analysis in leprosy patients reveals host factors associated with mycobacterial control - Annemieke Geluk 2. Implementation of Dapsone Hypersensitivity Syndrome (DHS) Biomolecular Predictive Test to reduce the incidence of DHS among Leprosy Patients in Papua - Hana Krismawati 3. Development and Application of ELISPOT, ELISA and Colloidal Gold Test for the Precise and Rapid Detection of Leprosy - Hongsheng Wang 4. Diagnostic clinical utility of granulocytes to lymphocytes ratio in patients with leprosy reactions - MANSI GUPTA	Oral free papers (4): Clinical relevance of skin biopsy in leprosy at the end of fixed duration WHO multi drug therapy (MDT): An Ambispective observational study - Jyoti Sethi Histopathological pitfalls in the diagnosis of leprosy - Suwash Baral The Important Role of Histopathology in Determining Leprosy Therapy - Epifania Fitriana Adna Value and limitations of nerve biopsy in the diagnosis and management of leprosy - SUJAI KUMAR SUNEETHA	Oral free papers (7): Innovative telacebec-based regimens to transform leprosy treatment and prophylaxis: preclinical consortium to support clinical trial designs -N atalya Serbina ASSOCIATION BETWEEN HUMAN LEUKOCYTE ANTIGEN HLA-B*13:01 AND DAPSONE-INDUCED HYPERSENSITIVITY REACTIONS IN NEPALESE LEPROSY PATIENTS - DIVYA RAJ SHAMSHER J B RANA Bedaquiline is Active and Efficacious against Leprosy -Roch Christian JOHNSON A single center, open label pilot study to evaluate the safety and efficacy of CC-11050 (dovramilast) in Nepalese patients with erythema nodosum leprosum (step 2): Trial Protocol - Mahesh Shah Comparison of WHO MDT (MBR) vs Alternate Leprosy Treatment (ALT) efficacy in MB leprosy patients by assessing anti-PGL-1 antibodies and viable bacterial load pre and post multidrug therapy - Tarun Narang Innovative Bactericidal Drugs Pulse Regimens - Redefining Leprosy treatment - Hemanta Kumar Kar Cosmetic and functional outcome of those underwent Clawhand correction with contracture release of PIP joints in longstanding deformities - Cornelius Noahyesuraj	Oral free papers (4): Assessment of stigma factors leading to social exclusion among women with leprosy – a comparative study in an urban setting - BHAGYASHREE Population based Active-Case-Finding for leprosy – outcome of providing additional funding to five experienced partner organisations in four countries - Katharine Jones Study on the Chemoprophylactic Application of Single-Dose Rifapentine in the Chinese Leprosy Population - WANG HONGSHENG Leprosy-Friendly Villages: How Influential Community Members Advocate for Resource Allocation for Leprosy Elimination - Denny Mustafa	Oral free papers (4): Does high ENLIST ENL severity scale (EESS) besides known risk factors at start of standard prednisolone course predict need for additional prednisolone within 24 weeks? - Vivek Vasudev Pai Clinical Spectrum of Leprosy with Reactions and Disabilities: A One-Year Study from a Tertiary Care Hospital in India - PENALA HARSHINI Need for other management of Musculoskeletal and Arthritic related pain in leprosy patients with severe lepra reactions. -K. Swapna Kumari Varied manifestations of leprosy posing diagnostic challenges – A case series - KONATHAN RAJYALAXMI
45
46	DAY 3, July 9 2025 - Wednesday
47	Room	Ballroom
48	Time	Ballroom
49		Room 1: Mengwi 1	Room 2: Mengwi 2	Room 3: Mengwi 3	Room 4: Mengwi 5	Room 5: Mengwi 6	Room 6 Mengwi 7	Room 7: Mengwi 8	Room 8: Legian 1	Room 9: Legian 2	Room 10: Pecatu 1 & 2
50	09.00 – 09.30 AM	Theme: NTD Neglected Tropical Disease (Other than leprosy) Lead talk + Chair: Tuberculosis, elephantiasis, etc. – Joseph N. Chukwu	Chair: Melani Marissa Oral free papers (9+1): Unveiling the surge of Lucio’s phenomenon: Case series of 19 patients in a tertiary referral hospital in Indonesia - Melani Marissa Improving Leprosy Training: A Comprehensive Global Review of Training Resources for Leprosy and Other Skin NTDs - Roos Geutjes, Ms Role of community pharmacist in early diagnosis and treatment of neglected tropical diseases: a case of leprosy in Nepal-Dr Ramesh Sharma Poudel Sustainability of People’s Organization – A Case Study of HANDA _ Michael Zhiqiang Chen Evaluation of a self-help intervention to promote the health and wellbeing of marginalised people including those living with leprosy in Nepal: a prospective, observational, cluster-based, cohort study with controls - Dilip Shrestha Trend of drug resistance in M. leprae isolates in leprosy patients of India from 2021 –2024- Itu Singh A study on effectiveness in early case detection in high endemic districts in Nepal - YAMNATH YOGI Factors Influencing Leprosy Case Detection in Bangladesh: A Study of Active Case Finding Effectiveness - KOMOL PALMA One Case Of Morbus Hansen Indeterminate Type - Luh Putu Venny Cempaka Sari	Theme: Meet the editor Lead talk + Chair: 1. Paul Saunderson 2. Ruth Peters 3. Liesbeth Mieras 4. Saba Lambert 5. Astri Ferdiana	Chair: Regitta Indira Agusni Oral free papers (10): Elucidation of Mycobacterium leprae-derived cell-free DNA in blood and urine samples from leprosy patients and their contacts in India - RAKESH YADAV Cross-sectional area (CSA) of uninvolved nerves by High-Resolution Ultrasound in suspected cases of leprosy - SUJAI KUMAR SUNEETHA Two blood-based biomarkers potentially useful in the diagnosis of leprosy detected by LC-MS - John Stewart Spencer Fatality in Lepromatous Leprosy with Bone Marrow Involvement: A Rare Case - Edelyne Chelsea Identification of HLA-B*13:01 Allele in Leprosy Patients with Dapsone Hypersensitivity Syndrome in Ambon - Mufqi Handaru Priyanto Serosurveys using a rapid, field-friendly test for detection of Mycobacterium leprae infection - Louise Pierneef Pure Neuritic Leprosy : A diagnostic challenge A Video demonstration of nerve and skin biopsy by a a novel single window technique - BETSY AMBOOKEN Unraveling Lucio Phenomenon: A Rare Leprosy-Associated Vasculopathy Mimicking Autoimmune Disorders - Limyanti Dwi Vicaria Mental Health of Women Affected by Leprosy – Chhavi Tyagi Epidemiological Trends of Leprosy Cases in Pre- and Post-Elimination Era: A Comprehensive District-Level Data from an In-Situ Leprosy Center - KANCHHA takahiroSHRESTHA	Theme: Therapeutic aspects Lead talk + Chairperson: Updates on management chronic leprosy ulcer – Medhi Denisa Alinda	Lead talk + Chair: Development of AI for management and diagnosis of Leprosy – Patricia deps.	Theme: Disability and rehabilitation Lead talk + Chair: Laser for tropical ulcer management – Naveen kothari	Chair: Zunarsih Oral free papers (9+1) : Evaluation of post-exposure prophylaxis with single dose rifampicin to household contacts of leprosy patients, Tiruvallur district, Tamil Nadu, Southern India, 2023 - A cross-sectional study - SRIDEVI GOVINDARAJAN Intake of the PEP++ randomised controlled trial: an enhanced chemoprophylaxis regimen to reduce the incidence of leprosy in four leprosy endemic countries. - Duane Hinders Evaluation of the cumulative incidence of leprosy up to two years after the administration of Rifampicin as post-exposure prophylaxis in Senegal -BATISTA GILBERT Strengthening Leprosy Case Detection and Care through Engagement of Formal and Informal Private Healthcare Providers - KANDUKURI ARUN KUMAR Health seeking behaviour and associated factors among leprosy patients in Colombo, Sri Lanka - Nilanthi Senanayake Community Resource Person Engagement in Active Leprosy Case Finding: A Pilot Study from South India - Aparna Srikantam Beyond the immune zones: Plantar lesions as a marker of high bacillary load in lepromatous leprosy - JYOTI SINGH Updating the List of Persons Affected by Leprosy with Disabilities and Assessment of Disability Status for Providing Services in Bihar, Chhattisgarh, and Jharkhand, India (2017–2022) - Sarbartha Roy Comparison of Serum Vitamin D Level and Vitamin D Receptor Gene FokI Polymorphism in Leprosy Patients with and without Trophic Ulcers: A Case-Control Study - Paulus Anthony Halim	Theme: Community Connect Session Lead talk + Chair: The involvement in research in India – Maya ranavare	Theme: Multidisciplinary session - Surgery – Willem Theuvenet - Ophthalmology – Swapan Samanta
51	09.00 – 09.30 AM	Oral free papers (7): The Lucio Phenomenon in Neglected Leprosy: A Rare Case Series - Nopriyati MapNTD: Enhancing Decision-Making with an Interactive Visualization Tool for Neglected Tropical Diseases - Veronica Schmitz TCR sequencing for TB-IGRA in Mycobacterium infections - Yang Degang Prevalence and Epidemiological characteristics of Skin Neglected Tropical Diseases (NTDs), and common Skin Diseases among Leprosy contacts: Implication of integrated Skin Disease approach, in East Hararghe Zone - Ephrem Mamo Gebrehiwot Uncovering the burden of leprosy and other (neglected) skin diseases in Sumba, Indonesia: a household surveillance study - Marlous L. Grijsen Hepatitis B virus infection in patients with leprosy at the Hospital for Tropical Diseases, London, United Kingdom - Stephen L. Walker Integrated survey to detect skin -related Neglected Tropical Diseases in Apta primary Health Center in Maharashtra state in India -A pilot study - Chandrakant Revankar		Oral free papers (3+1): Efficacy and safety of rifampicin, minocycline and clarithromycin monthly pulse regimen versus standard WHO multidrug regimen in leprosy: a randomized contract olled study - MINU S KANI ANTIMICROBIAL RESISTANCE IN M. LEPRAE IN KIRIBATI USING PCR AND SANGER SEQUENCING - Patrick Campbell Non-standard Treatment in Borderline Leprosy: A Case Report - Tanziela Firdausi Thahir Commonly Affected Skin Sites in Leprosy : A Systematic Literature Review - Anne Schoenmakers		Oral free papers (7): Improving Management of Leprosy ulcers through a community-based Self-Care intervention using a stepped wedge cluster randomized trial in South-East Nigeria - MEKA Anthony Obiamaka Removable off-loading device versus total contact cast to promote healing of planter ulcer in leprosy: a multi-centric, non-inferiority, randomized controlled trial -Karthikeyan Govindasamy Enhancing recovery: trophic ulcer management in Hansen’s disease with platelet rich fibrin - SHIKHA SHIVHARE Platelet Rich Fibrin versus Zinc Oxide Phenytoin Paste in Treatment of Trophic Ulcers in Leprosy Patients – A Comparative Study - Pravesh Valecha Cadexomer Iodine for Treatment of Ulceration on Erythema Nodosum Leprosum.: A Case Report - Fitri Yulianti Shortening Buruli ulcer treatment in western Africa: an update on the BLMs4BU trial -Roch Christian JOHNSON The Efficacy Of Rifampicin and Clarithromycin Combination in The Management of Histoid Hansen’s and Lucio Phenomenon - Khunadi Hubaya	Oral free papers (7): Evaluating User Experience of Kuesta: An Artificial Intelligence-Powered Leprosy Detection and Monitoring Application Using User Experience Questionnaire and Usability Testing - Dhelya Widasmara Strategic Gap Assessment Tool for Identifying Diagnostic and Technological Needs in Leprosy and Skin NTDs - Mowmita Basak Qualitative Insights from Frontline Health Workers and Early Ethnographic Observations: Findings from the WHO artificial intelligence-based Skin Neglected Tropical Disease App Assessment Study, Kenya - Emily Quilter Application of point-of-care quantitative immunodiagnostic test for detection of Mycobacterium leprae infection in a high endemic area in Brazil - Antoniella de Aguiar1, Louise Pierneef2, Hilma Solange Lopes Souza3, Carla Pires3, Marília Brasil Xavier3, Marcelo Távora Mira1 and Annemieke Geluk2 MaLeSQs – Artificial Intelligence, Digital System and Specialized Training Increase the Efficiency of Leprosy Detection Rates in a So-Called Non-Endemic Town - Mateus Mendonça Ramos Simões Implementation of a Digital Data Management System to Support Leprosy Morbidity Management and Disability Prevention (MMDP): Research Findings from Ghana - Stephen Adom Boateng Digital Measurement for Paduka (Footwear) for Persons Affected by Leprosy(DiMPLE)-KANDUKURI ARUN KUMAR	Oral free papers (7): Laser Therapy as a Promising Modality to Treat Leprosy Neuropathy: a Case Report - Eveline Hongo 3D Printed Hand Splints in Leprosy rehabilitation - MATHANRAJ DAVID Enhancing Social Reintegration of Persons Affected by Hansen’s disease: A Transitional Rehabilitation Approach by READ Nepal - Basudev Yadav INNOVATIVE APPROACHES IN THE MANAGEMENT & PREVENTION OF IMPAIRMENTS IN LEPROSY - Manoharan Sathish Kumar Paul Five cases of skin unusual pathogenic infections including leprosy presenting as limb skin nodules and ulcers - Yangying Liu Care after cure: management of the hidden disability of neuropathic pain in people living with leprosy - Andrew Rice Evaluating the Effectiveness of Community-Based Disability Management for Leprosy-Affected Individuals: A Retrospective Study in Two High-Burden Districts, Maharashtra, India - ASHUTOSHKUMAR BALKRISHNA PRABHAVALKAR		Oral free papers (7): Efficacy of Multidrug Therapy (MDT) and Detection of Transplacental Transmission Morbus Hansen during Pregnancy - Meta Sakina JAGRUTI Nepal: Accelerating Impact towards Ending NTDs through Women-Led Integrated WASH and NTDs Interventions - Ramesh Kumar Choudhary Women with leprosy in Sri Lanka. Do we know all? - H M A D M Wijesekara Reclaiming Agency: How Autonomy and Economic Empowerment Improve Mental Health for Women Affected by Leprosy - Christine Iyenrhe Bestman Psychological Distress Among Women in Leprosy-Affected Households in Northern Bangladesh: Depression, Anxiety, and Stress - Rishad Choudhury Robin An Exploration of Self-Care Practice and Factors Influencing Self-Care among People Affected by Leprosy in Nigeria using Social Practice Theory - Sunday Udo Pilot Result: Role of Community Resource Person for Sustainable OPLD - Smita Das	Oral free papers (7): Feasibility and Potential of Artificial Intelligence-Based Mobile Health Screening Tools for Enhancing the Detection of Leprosy and Other Neglected Tropical Skin Diseases at the Community Level in Senegal (West Africa) - Felicitas Schwermann A Retrospective Analysis of Documents and Occupational Therapy Outcomes in Leprosy Patients' Reconstructive Surgery - Sudip Auji Reconstructive Hand Surgery for Leprosy Patients with Grade 2Disabilities (G2D) - Iswahyudi Evaluation of tendon transfer surgery outcomes in children and adolescents for correction of claw fingers due to leprosy - ILAVARASI Techniques for the surgical correction of lagophthalmos secondary to leprosy: a systematic review - Matthew Willis Determinants of Activity Limitations and Safety Awareness in Nepalese Leprosy Patients undergoing Reconstructive Surgeries: A Hospital-based Study - JAGANATH MAHARJAN Lived experience of people physically changed by leprosy and reconstructive surgery - Eleanor McDevitt
52	09.30 – 11.00 AM
53	11:00 AM – 1:00 PM	Lunch Break
54	1:00 – 2:40 PM	Plenary 4: MC Opening 13.00–13.05 Chair & Co-Chair: M. Yulianto Listiawan & I.G.A.A Elis Indira 13.05–13.20 The Mental Health Burden Among Patients with Leprosy – Hendra Gunawan 13.20–13.35 Chasing Ideal Future – Luh Made Mas Rusyati 13.35–13.50 “Over 50 year in Leprosy – reflections” - Ben Naafs 13.55–14.10 Research on Leprosy in Indonesia – Cita Rosita Sigit Prakoeswa 14.10–14.25 Update management of Leprosy reaction – Hardianto Soebono 14.25–14.40 Global leprosy scenario and the new paradigm – Vivek Lal, Team Leader WHO Global Leprosy Programme. QnA
55	1:00 – 2:40 PM
56	2.40 – 3.00 PM	Tea Break
57	3.00 – 4.00 PM	General assembly of ILA (handling of the next ILC)
58	4:00 – 5:00 PM	Closing Ceremony 16.00–16.15 Report from the Chair of the Organizing Committee 16.15–16.25 Remarks by P. Narasimha Rao and announcement of the ILC 2028 host 16.25–16.35 Handover of the ILC Key 16.35–16.45 Closing Remarks 16.45–17.00 Official Closing of the Congress
59	19:00	Farewell Dinner

Main Congress

Workshop